生物活性 | |||
---|---|---|---|
描述 | MS1943 represents a pioneering orally bioavailable EZH2 selective degrader, demonstrating an IC50 value of 120 nM. It notably diminishes EZH2 protein levels across various triple-negative breast cancer (TNBC) and other cancer and noncancerous cell lines. Additionally, MS1943 robustly impedes the proliferation of multiple TNBC and other cancer cell lines[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.39mL 0.28mL 0.14mL |
6.95mL 1.39mL 0.70mL |
13.91mL 2.78mL 1.39mL |
参考文献 |
---|